Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer ’s type in rats
In conclusion, our results indicate the effectiveness of tramadol in preventing ICV-STZ-induced cognitive impairment as well as mito-oxidative stress. Further, these findings reveal the possibility of MOR agonist as a therapeutic approach for sporadic Alzheimer disease.
Source: Inflammopharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Alzheimer's | Brain | Dementia | Drugs & Pharmacology | International Medicine & Public Health | Mitochondrial Disease | Namenda | Neurology | Tramadol